St Jude

St. Jude Medical, Inc. announced U.S. Food and Drug Administration approval of the newest version of the Merlin.net™ Patient Care Network, a secure, Internet-based remote care system for patients with implanted medical devices.

St. Jude Medical, Inc. today announced European CE Mark approval of its Genesis® neurostimulation system for managing a form of chest pain known as chronic angina pectoris, or chronic angina.

New lead and cardiac resynchronization system design is expected to offer implanting physicians a simpler and quicker procedure and reduces the volume of the leads and device in the chest pocket for heart failure patients

St. Jude Medical, Inc. announced European CE Mark approval of its Libra® and LibraXP™ deep brain stimulation systems for treating the symptoms of Parkinson’s disease, a neurological disorder that progressively diminishes a person’s control over his or her movements and speech.

Study reports excellent long-term durability of the St. Jude Medical Biocor™ Stented Tissue Valve for mitral and aortic valve replacement

St. Jude Medical, Inc. (NYSE: STJ ) celebrates the 50th anniversary of the world’s first implantable pacemaker.

Advanced delivery system gives physicians more control to achieve consistent vascular closure

Silver dollar-sized medical device provides injured military skydiver with pain relief